Abstract
Lactobacillus strains have been shown to confer health benefits to the host including attenuation of intestinal inflammatory responses. However, the health benefits of lactobacilli are strain specific. The aim of this study was to determine whether <i>Lactobacillus fermentum</i> PC1 (PC1) cell wall extract (CW) and the spent culture supernatant (SCS) had the capacity to inhibit IL-8 production by <i>Salmonella</i> <i>enterica </i>serotype Typhimurium (<I>S</I>. Typhimurium) infected epithelial cells. Epithelial cell line, HT-29 was treated with CW or SCS of PC1 both pre- and post-infection with <I>S</I>. Typhimurium and the resultant levels of IL-8 protein was assayed. Both the CW and SCS of PC1 was shown to inhibit <I>S</I>. Typhimurium induced IL 8 production in HT-29 cells in the therapeutic and prophylactic models. Furthermore, a secreted molecule produced by PC1 responsible for this effect was identified and characterized. The molecule was produced in mid-stationary phase of growth. This active component was present in both the cell wall extracts and spent culture medium of PC1. The bioactive molecule(s) had a size of Mr 2-30KDa, was heat stable at 90°C for 30 min, insensitive to lipase, distinct from acetic and lactic acid, and optimal function at pH 4.5. The activity of the molecules was inactivated by Proteinase K, Na-metaperiodate and Trypsin indicating that the molecule(s) was a glycoprotein. The isolation of an immunomodulatory molecule that could be used in the treatment of <I>S</I>. Typhimurium infection would be of great value.
Highlights
Lactobacillus spp have a ‘generally regarded as safe’ status and are used extensively in foods
This study examines the capacity of PC1 spent culture supernatant (SCS) or cell wall extract (CW) to suppress S
HT-29 monolayers were incubated with CW extracts or SCS for 4 h at 37°C, tested for viability using modified MTT assay
Summary
Lactobacillus spp have a ‘generally regarded as safe’ status and are used extensively in foods They have been shown to confer protection to the host against several diseases. Their role in the protection of adults and infants against enteric bacterial infections has been known since the 1900s [1,2,3]. They can mediate protection via a variety of mechanisms including but not limited to enhancing the integrity of the epithelial barrier, colonisation resistance and production of antimicrobial molecules (reviewed in [4]).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
